Literature DB >> 8537149

Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction.

S M Wildhirt1, R R Dudek, H Suzuki, R J Bing.   

Abstract

Inducible nitric oxide synthase (iNOS), which catalyzes the reaction of L-arginine to L-citrulline and nitric oxide (NO), plays an important role in immune-mediated cardiac disorders. The present report summarizes and discusses findings on the induction of NOS in myocardial infarction of rabbits. iNOS was significantly increased in infarcted myocardium 48 h after coronary artery ligation. The effect persisted for 14 days and declined thereafter. Immunohistochemical localization revealed macrophages as a major source of iNOS expression; iNOS expression was also present in infarcted human myocardium. Increased iNOS activity appeared to be related to the induction of apoptosis in infiltrating macrophages and cardiomyocytes. Moreover, preferential inhibition of iNOS by S-methylisothiourea sulfate (SMT) resulted in significant improvement of left ventricular performance and increased regional myocardial blood flow. These findings suggest that selective inhibition of iNOS activity may provide a therapeutic strategy in cardiac disorders such as myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537149     DOI: 10.1016/0167-5273(95)02385-a

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

Review 1.  Nitric oxide-cyclic GMP signaling in stem cell differentiation.

Authors:  Kalpana Mujoo; Joshua S Krumenacker; Ferid Murad
Journal:  Free Radic Biol Med       Date:  2011-10-06       Impact factor: 7.376

2.  Acidic and basic fibroblast growth factors involved in cardiac angiogenesis following infarction.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Yuanjian Chen; Robert A Ahokas; Yao Sun
Journal:  Int J Cardiol       Date:  2010-08-02       Impact factor: 4.164

Review 3.  Pathophysiology and Advanced Hemodynamic Assessment of Cardiogenic Shock.

Authors:  Michael I Brener; Hannah R Rosenblum; Daniel Burkhoff
Journal:  Methodist Debakey Cardiovasc J       Date:  2020 Jan-Mar

Review 4.  Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatment.

Authors:  C de Zwaan; M J A P Daemen; W Th Hermens
Journal:  Neth Heart J       Date:  2001-04       Impact factor: 2.380

5.  The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A.

Authors:  Philip O'Reilly; Judy M Hickman-Davis; Philip McArdle; K Randall Young; Sadis Matalon
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

6.  The role of nitric oxide in endotoxin-induced cardiodepression.

Authors:  Alla G Portnychenko; Olga Yu Harmatina; Anatolij V Kotsuruba; Oleksij O Moybenko
Journal:  Exp Clin Cardiol       Date:  2005

7.  Increased inducible nitric oxide synthase expression in organs is associated with a higher severity of H5N1 influenza virus infection.

Authors:  Simon Burggraaf; John Bingham; Jean Payne; Wayne G Kimpton; John W Lowenthal; Andrew G D Bean
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

Review 8.  Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review.

Authors:  J B Weinberg
Journal:  Mol Med       Date:  1998-09       Impact factor: 6.354

9.  Mixture of MMP-2, MLC, and NOS Inhibitors Affects NO Metabolism and Protects Heart from Cardiac I/R Injury.

Authors:  Anna Krzywonos-Zawadzka; Aleksandra Franczak; Grzegorz Sawicki; Iwona Bil-Lula
Journal:  Cardiol Res Pract       Date:  2020-04-07       Impact factor: 1.866

10.  Nitric oxide inhibition rapidly increases blood pressure with no change in outcome in cardiogenic shock: the TRIUMPH trial.

Authors:  Réda Salem; Alexandre Mebazaa
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.